Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
J Chem Inf Model ; 51(12): 3113-30, 2011 Dec 27.
Artículo en Inglés | MEDLINE | ID: mdl-22035187

RESUMEN

Efficient substructure searching is a key requirement for any chemical information management system. In this paper, we describe the substructure search capabilities of ABCD, an integrated drug discovery informatics platform developed at Johnson & Johnson Pharmaceutical Research & Development, L.L.C. The solution consists of several algorithmic components: 1) a pattern mapping algorithm for solving the subgraph isomorphism problem, 2) an indexing scheme that enables very fast substructure searches on large structure files, 3) the incorporation of that indexing scheme into an Oracle cartridge to enable querying large relational databases through SQL, and 4) a cost estimation scheme that allows the Oracle cost-based optimizer to generate a good execution plan when a substructure search is combined with additional constraints in a single SQL query. The algorithm was tested on a public database comprising nearly 1 million molecules using 4,629 substructure queries, the vast majority of which were submitted by discovery scientists over the last 2.5 years of user acceptance testing of ABCD. 80.7% of these queries were completed in less than a second and 96.8% in less than ten seconds on a single CPU, while on eight processing cores these numbers increased to 93.2% and 99.7%, respectively. The slower queries involved extremely generic patterns that returned the entire database as screening hits and required extensive atom-by-atom verification.


Asunto(s)
Algoritmos , Descubrimiento de Drogas , Informática/métodos , Bibliotecas de Moléculas Pequeñas/química , Bases de Datos Factuales , Descubrimiento de Drogas/economía , Informática/economía , Factores de Tiempo
2.
J Chem Inf Model ; 47(6): 1999-2014, 2007.
Artículo en Inglés | MEDLINE | ID: mdl-17973472

RESUMEN

We present ABCD, an integrated drug discovery informatics platform developed at Johnson & Johnson Pharmaceutical Research & Development, L.L.C. ABCD is an attempt to bridge multiple continents, data systems, and cultures using modern information technology and to provide scientists with tools that allow them to analyze multifactorial SAR and make informed, data-driven decisions. The system consists of three major components: (1) a data warehouse, which combines data from multiple chemical and pharmacological transactional databases, designed for supreme query performance; (2) a state-of-the-art application suite, which facilitates data upload, retrieval, mining, and reporting, and (3) a workspace, which facilitates collaboration and data sharing by allowing users to share queries, templates, results, and reports across project teams, campuses, and other organizational units. Chemical intelligence, performance, and analytical sophistication lie at the heart of the new system, which was developed entirely in-house. ABCD is used routinely by more than 1000 scientists around the world and is rapidly expanding into other functional areas within the J&J organization.


Asunto(s)
Biología , Biología Computacional , Computadores , Imagenología Tridimensional
3.
J Med Chem ; 50(24): 5926-37, 2007 Nov 29.
Artículo en Inglés | MEDLINE | ID: mdl-17958407

RESUMEN

We present structure-activity relationship (SAR) maps, a new, intuitive method for visualizing SARs targeted specifically at medicinal chemists. The method renders an R-group decomposition of a chemical series as a rectangular matrix of cells, each representing a unique combination of R-groups and thus a unique compound. Color-coding the cells by chemical property or biological activity allows patterns to be easily identified and exploited. SAR maps allow the medicinal chemist to interactively analyze complicated datasets with multiple R-group dimensions, rapidly correlate substituent structure and biological activity, assess additivity of substituent effects, identify missing analogs and screening data, and create compelling graphical representations for presentation and publication. We believe that this method fills a long-standing gap in the medicinal chemist's toolset for understanding and rationalizing SAR.


Asunto(s)
Diseño de Fármacos , Relación Estructura-Actividad , Proteína Quinasa CDC2/antagonistas & inhibidores , Química Farmacéutica , Modelos Moleculares , Conformación Molecular , Piperazinas/química , Piperidinas/química , Estereoisomerismo , Triazoles/química , Receptor 2 de Factores de Crecimiento Endotelial Vascular/antagonistas & inhibidores
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...